InvestorsHub Logo
Followers 2
Posts 402
Boards Moderated 0
Alias Born 11/06/2013

Re: None

Wednesday, 11/09/2016 3:37:06 AM

Wednesday, November 09, 2016 3:37:06 AM

Post# of 16445
New Update From The Company

NanoLogix is pleased to announce the recent peer-reviewed research paper published in the Journal of Infectious Diseases in Obstetrics and Gynecology has been rated by AltMetric and Kudos, two services for tracking published research.  In AltMetric, it was ranked as #1 out of 128 articles published in the above mentioned journal. In Kudos, the research paper was ranked in the top five percent of over 100,000 research outputs.

In addition, CEO Bret Barnhizer has been in meetings in Houston with both Drs. Sebastian and Jonathan Faro, along with investors, to plan and execute the next steps in the evolution of N-Assay studies, certifications, production, and marketing plans. The initial production has been and will be in Texas for the immediate future, during which time NanoLogix will be pursuing further plans to establish production in Ohio.


Good to know.

EI